日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulation

强效且选择性的LSD1抑制剂DC551040揭示了一种有前景的AML联合疗法，并有助于深入了解表观遗传失调。

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-026-02637-0
Wang, Jiang; Wang, Hanlin; Du, Runhua; Li, Chunpu; Su, Mingbo; Wang, Shuni; Kan, Weijuan; Liu, Guobin; Zhang, Yu; Hu, Xiaobei; Gao, Feng; Xu, Gaoya; Li, Cong; Zhu, Wei; Ye, Yunfei; Sheng, Li; Shi, Yuqiang; Shao, Yingying; Song, Jiangzhou; Wang, Yuxian; Wang, Bo; Zhou, Yubo; Huang, He; Li, Jia; Liu, Hong
LSD1
表观遗传
发表日期：2026
文献求助 收藏

Sequential anlotinib and camrelizumab combination therapy achieves exceptional survival in multi-driver mutated, TMB-low/PD-L1-low/MSS pulmonary sarcomatoid carcinoma: case report and literature review

序贯安罗替尼联合卡瑞利珠单抗治疗在多驱动基因突变、TMB低/PD-L1低/MSS型肺肉瘤样癌中取得了显著的生存获益：病例报告及文献综述

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1718918
Zhu, Jun; Zhu, Ai; Li, Gang; Liu, Lidong; Gao, Ziran; Liu, Jiayun; Ye, Yunfei; Zhu, Xunzhi; Li, Yi; Chen, Hong; Huang, Meijin
PD-L1
肿瘤
肿瘤免疫
多发性硬化症
发表日期：2025
文献求助 收藏

RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3.

RNF149 通过降解 IRF3 来调节 I 型 IFN 先天性抗病毒免疫反应

期刊:PLoS Pathogens
影响因子:4.9
doi:10.1371/journal.ppat.1013051
Wu Mengyun, Cai Jiamin, Qiao Guodong, Li Xiaoping, Zhou Ji, Xu Fei, Ye Yunfei, Wang Yufeng, Xu Xuena, Li Jiaoyang, Tian Xiaoyu, Shao Yu, Dong Chunsheng, Chen Zhengrong, Hao Chuangli, Yang Yi, Zhang Jinping
其它
Viral
发表日期：2025
文献求助 收藏

Target-Based Biofilm Inhibition and Antibiotic Enhancement Strategy by MiR.101.3p Using DNA Tetrahedrons

利用DNA四面体靶向miR.101.3p抑制生物膜和增强抗生素疗效的策略

期刊:Journal of Innate Immunity
影响因子:3
doi:10.1159/000549134
Sun, Yin He Richard; Ye, Yunfei; Shahrour, Hawraa; Oglesby, Irene K; O Apos Neill, Eoghan; Greene, Catherine M
微生物学
发表日期：2025
文献求助 收藏

miR-17-5p: bridging the gap between disease mechanisms and therapeutic innovations

miR-17-5p：弥合疾病机制与治疗创新之间的鸿沟

期刊:Epigenomics
影响因子:2.6
doi:10.1080/17501911.2025.2572285
Ye, Yunfei; Sun, Yin He Richard; Oglesby, Irene K; Zheng, Yiran; Greene, Catherine M
发表日期：2025
文献求助 收藏

Cumulative dose assessment with transformer-based deformable image registration addition for cervical cancer patients

宫颈癌患者累积剂量评估：基于Transformer的可变形图像配准技术

期刊:Journal of Applied Clinical Medical Physics
影响因子:2.2
doi:10.1002/acm2.70135
Zhou, Dongdong; Shao, Yuheng; Wan, Fuying; Chen, Jiayi; Zhang, Yumeng; Feng, Jiaqi; Ye, Yunfei; Zhou, Jinglan; Zeng, Fubin; Chen, Qi; Wang, Shaobin; Lu, Heqing; Yang, Liang
宫颈癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A novel function and mechanism of ischemia-induced retinal astrocyte-derived exosomes for RGC apoptosis of ischemic retinopathy

缺血诱导视网膜星形胶质细胞来源的外泌体对缺血性视网膜病变RGC凋亡的新功能和机制

期刊:Molecular Therapy-Nucleic Acids
影响因子:6.5
doi:10.1016/j.omtn.2024.102209
Xiaoyuan Ye, Yunfei Liu, Congying Chen, Yimeng Sun, Fan Li, Yunzhao Fu, Jiawen Luo, Lishi Su, Wei Chi
信号转导
细胞生物学
胶质细胞
Apoptosis
发表日期：2024
文献求助 收藏

microRNAs: a new class of endogenous antimicrobials for the treatment of infections in cystic fibrosis and beyond

微RNA：一类新型内源性抗菌剂，可用于治疗囊性纤维化及其他疾病的感染

期刊:Future Microbiology
影响因子:2.4
doi:10.1080/17460913.2024.2357971
Ye, Yunfei; Richard Sun, Yin He; Fitzpatrick, Fidelma; M Greene, Catherine
炎症/感染
发表日期：2024
文献求助 收藏

GRK2-YAP signaling is implicated in pulmonary arterial hypertension development

GRK2-YAP 信号与肺动脉高压发展有关

期刊:Chinese Medical Journal
影响因子:
doi:10.1097/CM9.0000000000002946
Peng Ye, Yunfei Deng, Yue Gu, Pengfei Liu, Jie Luo, Jiangqin Pu, Jingyu Chen, Yu Huang, Nanping Wang, Yong Ji, Shaoliang Chen
信号转导
发表日期：2024
文献求助 收藏

An optimal control chart for finite matrix sequences at some unknown change point

有限矩阵序列在某个未知变化点处的最优控制图

期刊:Journal of Applied Statistics
影响因子:1.1
doi:10.1080/02664763.2020.1772208
Ye, Yunfei; Han, Dong
发表日期：2021
文献求助 收藏